Study resultsDREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update 27.09.2024 / 22:30 CET/CESTThe issuer is solely responsible for the content of this ...
SAN DIEGO, CA / ACCESSWIRE / September 27, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe ...
EuCorVac-19 EuCorVac-19, a COVID-19 vaccine candidate developed by EuBiologics and POP Biotechnologies BUFFALO, N.Y., ...
BUFFALO, NY / ACCESSWIRE / September 27, 2024 / POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical company, ...
LEO Pharma A/S, a global leader in medical dermatology, today announced positive results from the Phase 2a Mechanism of Action (MoA) trial, which assessed the mechanistic impact of investigational ...
Epitopea, a transatlantic cancer immunotherapy company, and CQDM are proud to announce the launch of a collaborative research project between Epitopea and Université de Montréal (UdeM), a leading ...
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotypeFollowing recent approvals in the EU and China, the US approval is ...
Today is European Myeloma Day, a date dedicated to raising awareness of key issues affecting myeloma patients across Europe. This year, Myeloma Patients Europe (MPE) is highlighting the role of ...
Scientists now have a mathematical measure for 250 million manuscripts ~ As part of its commitment to improving transparency in scientific publishing, Open Access science company DeSci Labs has ...
Bayer News - AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies
Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced a new strategic collaboration with ...
Indicated for adult and pediatric patients 12 years of age and older with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) Leiden, the Netherlands, September 26, 2024: Pharming Group ...
Syndicate has today announced the first cohort of awardees of its Collaborative Discovery Programme (CDP) funding.The £3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback